Solis Pharmachem Private Limited, a amalgamated private limited company, was established on 03 December 2019 in Ankleshwar, Gujarat, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24100GJ2019PTC111161. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹24.76 Cr.
Employing 26 professional, Its leadership includes Anil Kumar Jain (Director), Samir Dhaga (Director), Rajnish Sarna (Director). Past directors included Smithaa Knachuthan Nair, Nomita Mathur, Anil Kumar Jain. Its latest AGM occurred on 02 August 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No. 4707/A/5 Sentogen Plot , Near Lyka Chokdi, Ankleshwar, Gujarat, 393002.
U24100GJ2019PTC111161
111161
03 December 2019
₹25.00 Cr
₹24.76 Cr
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Solis Pharmachem Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Jain | Director | 02 Jun 2023 | Current |
| Samir Dhaga | Director | 02 Jun 2023 | Current |
| Rajnish Sarna | Director | 02 Jun 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2020 | Past |
| Pramod Abcsdd | Director | 18 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 01 Aug 2023 | Past |
| Pramod Abcsdd | Director | 02 Jun 2023 | Past |
| Pramod Abcsdd | Additional Director | 01 Aug 2023 | Past |
| Pramod Abcsdd | Director | 02 Jun 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Solis Pharmachem Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 46.22% increase in profit. The company's net worth Soared by an impressive increase of 305.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Solis Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Solis Pharmachem has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Solis Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solis Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Solis Pharmachem Private Limited last Annual general meeting of members was held on 02 Aug 2023 as per latest MCA records. was documented.
The activity Anil Kumar Jain was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 6 months . was completed.
Mansi Bansal was appointed as a Company Secretary was appointed as a Company Secretary on 02 Jun 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.
Samir Dhaga was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.
The activity Rajnish Sarna was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 6 months . was completed.
The activity Solis Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad. was completed.
The CIN of Solis Pharmachem Private Limited is U24100GJ2019PTC111161.
Solis Pharmachem Private Limited is headquartered at Plot No. 4707/A/5 Sentogen Plot , Near Lyka Chokdi, Ankleshwar, Gujarat, 393002.
Solis Pharmachem Private Limited was incorporated on 03 December 2019.
The current directors of Solis Pharmachem Private Limited are
The primary industry of Solis Pharmachem Private Limited is Manufacturing.
Solis Pharmachem Private Limited is unlisted.
The authorized capital of Solis Pharmachem Private Limited is ₹25.00 Cr, and the paid-up capital is ₹24.76 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX